Fluorescentia is developing an evidence-based platform for therapeutic drug monitoring and precision dosing that leverages breakthrough fluorescent sensor technology developed at the University of Sydney. Using the power of data collected by Fluorescentia's core technology, we are on a mission to improve outcomes for patients undergoing chemotherapy.
| Employees | 3 (1 on RocketReach) |
| Founded | 2023 |
| Industry | Medical Equipment Manufacturing |
Looking for a particular Fluorescentia employee's phone or email?
Elizabeth New is the Chief Science and Technology Officer of Fluorescentia.
1 people are employed at Fluorescentia.
Fluorescentia is based in Melbourne, Victoria.